60
Participants
Start Date
December 28, 2023
Primary Completion Date
July 30, 2026
Study Completion Date
October 31, 2026
LIQ861
trepostinil inhalation powder
RECRUITING
NYU Langone Medical Center, New York
RECRUITING
University of Rochester, Rochester
RECRUITING
University of North Carolina at Chapel Hill, Chapel Hill
RECRUITING
Medical University of South Carolina, Charleston
RECRUITING
Advent Health, Orlando
RECRUITING
Tampa General Hospital Center of Research Excellence, Tampa
RECRUITING
Norton Pulmonary Specialists, Louisville
RECRUITING
University of Cincinnati Health, Cincinnati
RECRUITING
Vincent Medical Group, Indianapolis
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
University of Minnesota, Minneapolis
RECRUITING
Houston Methodist, Houston
RECRUITING
National Jewish Health, Denver
RECRUITING
University of Utah, Salt Lake City
RECRUITING
Arizona Pulmonary Specialists, Phoenix
RECRUITING
UCLA Westwood, Los Angeles
RECRUITING
University of California San Diego, La Jolla
RECRUITING
The Medical Research Group, Inc., Fresno
RECRUITING
UCSF, San Francisco
RECRUITING
UC Davis, Sacramento
RECRUITING
Summit Health, Bend
RECRUITING
Hartford Hospital, Hartford
RECRUITING
Tufts Medical Center, Boston
Lead Sponsor
Liquidia Technologies, Inc.
INDUSTRY